RhumbLine Advisers’s Agile Therapeutics, Inc AGRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33	Closed	-$138K	–	3147
2021 Q1	$138K	Sell	33 -2	-6%	-$8.36K	﹤0.01%	2900
2020 Q4	$200K	Buy	35 +3	+9%	+$17.1K	﹤0.01%	2839
2020 Q3	$195K	Sell	32 -5	-14%	-$30.5K	﹤0.01%	2699
2020 Q2	$208K	Buy	+37	New	+$208K	﹤0.01%	2752